相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
RANKL Expression, Function, and Therapeutic Targeting in Multiple Myeloma and Chronic Lymphocytic Leukemia
Benjamin Joachim Schmiedel et al.
CANCER RESEARCH (2013)
Generation and Preclinical Characterization of a Fc-optimized GITR-Ig Fusion Protein for Induction of NK Cell Reactivity Against Leukemia
Benjamin Joachim Schmiedel et al.
MOLECULAR THERAPY (2013)
Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies
Ursula J. E. Seidel et al.
FRONTIERS IN IMMUNOLOGY (2013)
Gene-engineered T cells for cancer therapy
Michael H. Kershaw et al.
NATURE REVIEWS CANCER (2013)
Properties of mouse and human IgG receptors and their contribution to disease models
Pierre Bruhns
BLOOD (2012)
4-1BB ligand modulates direct and Rituximab-induced NK-cell reactivity in chronic lymphocytic leukemia
Corina Buechele et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Obinutuzumab for the treatment of lymphoproliferative disorders
Carolyn Owen et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses
Julia Hilpert et al.
JOURNAL OF IMMUNOLOGY (2012)
Glucocorticoid-induced TNFR-related protein (GITR) ligand modulates cytokine release and NK cell reactivity in chronic lymphocytic leukemia (CLL)
C. Buechele et al.
LEUKEMIA (2012)
Treatment of HER2-positive breast cancer: current status and future perspectives
Carlos L. Arteaga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
Maria R. Parkhurst et al.
CLINICAL CANCER RESEARCH (2011)
Human NK receptors: From the molecules to the therapy of high risk leukemias
Lorenzo Moretta et al.
FEBS LETTERS (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
In vivo assay of human NK-dependent ADCC using NOD/SCID/γcnull (NOG) mice
Miho Shiokawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies
Holly M. Horton et al.
BLOOD (2010)
The clinical application of monoclonal antibodies in chronic lymphocytic leukemia
Samantha M. Jaglowski et al.
BLOOD (2010)
In vivo Cytotoxicity of Type I CD20 Antibodies Critically Depends on Fc Receptor ITAM Signaling
Simone de Haij et al.
CANCER RESEARCH (2010)
Natural Killer Cell Education and Tolerance
Mark T. Orr et al.
CELL (2010)
Rituximab A Review of its Use in Chronic Lymphocytic Leukaemia, Low-Grade or Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
Gillian M. Keating
DRUGS (2010)
Evolution of anti-CD20 monoclonal antibody therapeutics in oncology
Ezogelin Oflazoglu et al.
MABS (2010)
Anti-CD30 Antibodies for Hodgkin Lymphoma
Kelley V. Foyil et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2010)
Strategies and challenges for the next generation of therapeutic antibodies
Alain Beck et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Pharmacokinetics of CTLA4Ig fusion protein in healthy volunteers and patients with rheumatoid arthritis
Ying Ma et al.
ACTA PHARMACOLOGICA SINICA (2009)
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors
Yenan T. Bryceson et al.
BLOOD (2009)
Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Protein Ligand Subverts Immunosurveillance of Acute Myeloid Leukemia in Humans
Tina Baessler et al.
CANCER RESEARCH (2009)
The Kinase Inhibitors Sunitinib and Sorafenib Differentially Affect NK Cell Antitumor Reactivity In Vitro
Matthias Krusch et al.
JOURNAL OF IMMUNOLOGY (2009)
Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia
Holly M. Horton et al.
CANCER RESEARCH (2008)
Direct and natural killer cell-mediated antitumor effects of low-dose Bortezomib in hepatocellular carcinoma
Sorin Armeanu et al.
CLINICAL CANCER RESEARCH (2008)
Tumor cell recognition by the NK cell activating receptor NKG2D
Yenan T. Bryceson et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Chimeric NKG2D-Modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways
Tong Zhang et al.
CANCER RESEARCH (2007)
Engineered antibody Fc variants with enhanced effector function
GA Lazar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor
Tong Zhang et al.
CANCER RESEARCH (2006)
CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells
JA Bowles et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia
EJ Feldman et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih et al.
BLOOD (2003)
Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding
HR Salih et al.
JOURNAL OF IMMUNOLOGY (2002)
Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells
MW Lowdell et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
分享论文
